Psychosis in children and youth: Focus on early-onset schizophrenia

Pediatrics in Review

Volumn 34, Issue 7, 2013, Pages 296-306

  Abidi, Sabina ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ARTICLE; HIGH RISK PATIENT; HUMAN; INCIDENCE; PATHOGENESIS; PREVALENCE; PROGNOSIS; PSYCHOSIS; SCHIZOPHRENIA;

ADOLESCENT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; MARIJUANA ABUSE; PROGNOSIS; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; RISK ASSESSMENT; SCHIZOPHRENIA; UNITED STATES;

EID: 84880109951     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.34-7-296     Document Type: Article

References (13)

1. Algon S, Yi J, Calkins ME, Kohler C, Borgmann-Winter KE. Evaluation and treatment of children and adolescents with psychotic symptoms. Curr Psychiatry Rep. 2012;14(2):101-110
2. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
3. Masi G, Mucci M, Pari C. Children with schizophrenia: clinical picture and pharmacological treatment. CNS Drugs. 2006;20(10): 841-866
4. van Os J, Kapur S. Schizophrenia. Lancet. 2009;374(9690): 635-645
5. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67-76
6. Guillin O, Abi-Dargham A, Laruelle M. Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol. 2007;78:1-39
7. Vita A, De Peri L, Silenzi C, Dieci M. Brain morphology in firstepisode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res. 2009;108:3-10
8. McGuire PK, Jones P, Harvey I, Williams M, McGuffin P, Murray RM. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophr Res. 1995;15(3):277-281
9. Andréasson S, Allebeck P, Engström A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet. 1987;2(8574):1483-1486
10. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull. 2005;31 (3):608-612
11. Lieberman JA, Stroup TS, McEvoy JP, et al; Clinical Antipsy-chotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223
12. Findling RL, Johnson JL, McClellan J, et al. Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. J Am Acad Child Adolesc Psychiatry. 2010;49(6):583-594, quiz 632
13. The Canadian Psychiatric Association Working Group. Clinical practice guidelines for the treatment of schizophrenia. Can J Psychiatry. 2005;50(13 suppl 1):7S-57S.